Ireland is an “outlier” in not opposing European Union reforms of the pharmaceutical industry that would potentially damage ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

While the drug industry was spared that day, he clearly stated that it was next in line. “The pharmaceutical companies are ...

Lilly, Johnson & Johnson, Novartis and AstraZeneca have now announced manufacturing investments in the U.S., trying to ...

Effective April 5, the United States imposed a 10% baseline tariff on imports from nearly all countries, excluding products from Canada and ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Potential US tariffs add urgency to the EU’s pharma regulation debate, balancing industry calls for innovation against ...